EVOMED1, OOO, Saint Petersburg

Economic indicators

Net profit (RAS) of EVOMED1, OOO grew over 2023 by 36.27% to 402.00 thousand RUB from 295.00 thousand RUB over 2022, the company informed.

Revenue decreased in the accounting period by 8.83% to 12.73 million RUB from 13.96 million RUB in 2022.

Net profit (RAS) of EVOMED1, OOO grew over 2022 by 10.90% to 295.00 thousand RUB from 266.00 thousand RUB over 2021, the company informed.

Revenue decreased in the accounting period by 6.75% to 13.96 million RUB from 14.97 million RUB in 2021.

Net profit (RAS) of EVOMED1, OOO dropped in 2021 5.68 times to 266.00 thousand RUB from 1.51 million RUB over the same period in 2020, the company informed.

Revenue increased in the accounting period by 2.94% to 14.97 million RUB from 14.54 million RUB over 2020.

Net profit (RAS) of EVOMED1, OOO grew over 2020 3.01 times to 1.51 million RUB from 502.00 thousand RUB over 2019, the company informed.

Revenue increased in the accounting period by 6.54% to 14.54 million RUB from 13.65 million RUB over 2019.

Net profit (RAS) of EVOMED1, OOO grew over 2019 by 1.83% to 502.00 thousand RUB from 493.00 thousand RUB over 2018, the company informed.

Revenue decreased in the accounting period by 9.22% to 13.65 million RUB from 15.03 million RUB in 2018.

Net profit (RAS) of EVOMED1, OOO grew over 2018 3.18 times to 493.00 thousand RUB from 155.00 thousand RUB over 2017, the company informed.

Revenue increased in the accounting period 2.55 times to 15.03 million RUB from 5.89 million RUB over 2017; cost of goods sold grew 2.55 times to 14.40 million RUB from 5.64 million RUB; sales profit went up 2.56 times to 632.00 thousand RUB from 247.00 thousand RUB.

Companies in the region

• ARKADA-INVEST
• KONTAKT-M
• TRP
• TEPLOSTROY
• KOMPANIYA EKOTEKH